Department of Medicine, School of Medicine, Cardiff University, Cardiff, UK.
Diabet Med. 2010 Aug;27(8):938-48. doi: 10.1111/j.1464-5491.2010.03040.x.
The purpose of this study was to characterize the financial cost and efficacy of primary care treatment for diabetes in the United Kingdom from 1997 to 2007.
Retrospective data were analysed for people with Type 1 and Type 2 diabetes along with matched control subjects using data from The Health Improvement Network. Costs were attributed from published sources and adjusted for price inflation. Type 2 diabetes was analysed by five commonly used treatment regimens.
It was possible to identify 126 052 people for inclusion: 11 300 (8.9%) with Type 1 diabetes and 114 752 (91.1%) with Type 2. The overall mean prescribing costs per person per year (pppy) increased markedly for people with diabetes from 1997 to 2007: for Type 1, from 573 pounds to 1014 pounds pppy (+77%), and for Type 2, from 39 pounds to 740 pounds pppy (+89%). In 2007, diabetes-treatment-specific prescribing represented 57% of prescribing costs in Type 1 diabetes and 28% in Type 2 diabetes. In Type 2 diabetes there was a mean of 5.4 primary care consultations in 1997, increasing to 11.5 pppy in 2007 (+112%). In 1997 the total mean cost of primary care treatment for Type 2 diabetes was 602 pounds pppy, increasing to 1080 pounds in 2007. In Type 1 diabetes, the mean glycated haemoglobin decreased by 0.1% from 8.8% in 2001 to 8.7% in 2007; the corresponding change using insulin in Type 2 diabetes was also 0.1%. Greater improvement in blood pressure and lipids was evident.
Over the 10 year period to 2007, diabetes-related primary care adjusted costs increased considerably, whereas glycated haemoglobin values did not improve at all over the same period.
本研究旨在描述 1997 年至 2007 年期间英国初级保健治疗糖尿病的财务成本和效果。
使用来自健康改善网络的数据，对 1 型和 2 型糖尿病患者以及匹配的对照患者进行回顾性数据分析。成本来自已发表的资源，并根据物价通胀进行调整。2 型糖尿病按五种常用治疗方案进行分析。
共纳入 126052 人：11300 人（8.9%）为 1 型糖尿病，114752 人（91.1%）为 2 型糖尿病。1997 年至 2007 年，糖尿病患者的人均年处方费用（pppy）显著增加：1 型糖尿病从 573 英镑增加到 1014 英镑 pppy（+77%），2 型糖尿病从 39 英镑增加到 740 英镑 pppy（+89%）。2007 年，糖尿病治疗特异性处方占 1 型糖尿病处方费用的 57%，占 2 型糖尿病的 28%。2 型糖尿病患者在 1997 年有平均 5.4 次初级保健就诊，2007 年增加到 11.5 pppy（+112%）。1997 年，2 型糖尿病患者初级保健治疗的总平均费用为 602 英镑 pppy，2007 年增加到 1080 英镑。在 1 型糖尿病中，糖化血红蛋白从 2001 年的 8.8%下降到 2007 年的 8.7%，下降了 0.1%；2 型糖尿病中使用胰岛素的相应变化也是 0.1%。血压和血脂的改善更为明显。
在 2007 年的 10 年期间，与糖尿病相关的初级保健调整成本大幅增加，而在同一时期，糖化血红蛋白值根本没有改善。
